Evaluation of a Locoregional Anesthesia Protocol by Pudendal Block in Reconstructive Surgery Clitoral
DORECLI
"Evaluation of a Locoregional Anesthesia Protocol by Pudendal Block in Reconstructive Surgery Clitoral " Pudendal Block in Clitoral Surgery (Pain REparation CLItoris)
1 other identifier
interventional
78
1 country
1
Brief Summary
Reconstructive surgery of the clitoris is part of the care offered during a process of care of women victims of MSF. It consists in reconstituting a clitoral neogland after removal of the vulvar excisional scar and recovery of the remaining clitoris. Studies that have monitoring the implementation of this surgery show that it improves the well-being of the patients, brings benefits anatomically, sexual health, personal development, and in the long term decreases chronic pain. Currently the standard method used in the usual care of the patient is: general anesthesia with an intravenous analgesic protocol then oral without anesthesia regional loco The pudendal block that the investigators want to evaluate in this research, is a technique that has made proven in several types of surgery, associated with very few complications and easily reproducible.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2021
CompletedFirst Posted
Study publicly available on registry
September 27, 2021
CompletedStudy Start
First participant enrolled
October 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2023
CompletedMarch 14, 2022
September 1, 2021
1.2 years
September 13, 2021
February 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
decrease in the mean of the self-reported pain scores in the first 24 hours
decrease in the mean of the self-reported pain scores in the first 24 hours using a Numerical visual scale
24 hours
Secondary Outcomes (1)
decrease in pain on the EVN at 2 hours, 6 hours , Day 1 and Day 7 postoperative
2 hours, 6 hours, Day 1 and Day 7 postoperative
Study Arms (2)
Pudendal block
ACTIVE COMPARATORUltrasound-guided bilateral pudendal block at the start of surgery, in gynecological position: injection of 15 mL of 0.475% Naropein in each ischiorectal fossa.
the standard method
OTHEROperated and anesthetized patients according to the standard method within the department
Interventions
general anesthesia with an intravenous analgesic protocol then oral without anesthesia regional loco
Eligibility Criteria
You may qualify if:
- Major patient,
- With the indication of a clitoral repair surgery
- Having expressed their free and informed written consent
- Affiliated with a social security scheme
You may not qualify if:
- \- Contraindication to the pudendal block technique: notably :
- blood crass disorder
- allergy to Naropein
- infection at the injection site - Poor understanding of the interest of the practice proposed experimental
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Camby
Montreuil, 93100, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2021
First Posted
September 27, 2021
Study Start
October 14, 2021
Primary Completion
January 1, 2023
Study Completion
January 1, 2023
Last Updated
March 14, 2022
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share